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Abstract
Background: It is widely accepted that the highly error prone replication process of influenza A virus (IAV), together with
viral genome assortment, facilitates the efficient evolutionary capacity of IAV. Therefore, it has been logically assumed that
the enzyme responsible for viral RNA replication process, influenza virus type A RNA polymerase (IAV Pol), is a highly error-
prone polymerase which provides the genomic mutations necessary for viral evolution and host adaptation. Importantly,
however, the actual enzyme fidelity of IAV RNA polymerase has never been characterized.
Principal Findings: Here we established new biochemical assay conditions that enabled us to assess both polymerase
activity with physiological NTP pools and enzyme fidelity of IAV Pol. We report that IAV Pol displays highly active RNA-
dependent RNA polymerase activity at unbiased physiological NTP substrate concentrations. With this robust enzyme
activity, for the first time, we were able to compare the enzyme fidelity of IAV Pol complex with that of bacterial phage T7
RNA polymerase and the reverse transcriptases (RT) of human immunodeficiency virus (HIV-1) and murine leukemia virus
(MuLV), which are known to be low and high fidelity enzymes, respectively. We observed that IAV Pol displayed significantly
higher fidelity than HIV-1 RT and T7 RNA polymerase and equivalent or higher fidelity than MuLV RT. In addition, the IAV Pol
complex showed increased fidelity at lower temperatures. Moreover, upon replacement of Mg
++ with Mn
++, IAV Pol
displayed increased polymerase activity, but with significantly reduced processivity, and misincorporation was slightly
elevated in the presence of Mn
++. Finally, when the IAV nucleoprotein (NP) was included in the reactions, the IAV Pol
complex exhibited enhanced polymerase activity with increased fidelity.
Significance: Our study indicates that IAV Pol is a high fidelity enzyme. We envision that the high fidelity nature of IAV Pol
may be important to counter-balance the multiple rounds of IAV genome amplification per infection cycle, which provides
IAV Pol with ample opportunities to generate and amplify genomic founder mutations, and thus achieve optimal viral
mutagenesis for its evolution.
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Introduction
The high genetic diversity of influenza A virus (IAV), together
with gene reassortment, forms viral quasispecies which enable IAV
to acquire its efficient host adaptability. It is widely accepted that
the efficient evolutionary capacity of IAV is facilitated by its highly
error-prone replication process [1,2]. Every genome copy
packaged in newly produced viral progenies is synthesized
exclusively by the IAV RNA polymerase (Pol), and thus it has
been logically assumed that IAV Pol is a highly error-prone
polymerase which provides the genomic mutations necessary for
viral evolution and host adaptation. Importantly, however, the
actual enzyme fidelity of IAV RNA polymerase, which is the main
driving force for viral mutation synthesis, has never been
characterized. On the other hand, human immunodeficiency
virus type 1 (HIV-1) is also well known for its genomic
hypermutability [3,4], and indeed HIV-1 DNA polymerase, called
reverse transcriptase (RT), is the most error prone DNA
polymerase among those involved in genome replication [5].
However, the replication strategy of these polymerases is very
different. HIV-1 RT replicates viral genomes only twice per
infection cycle, and every RNA genome in the HIV-1progeny
virions is actually produced by host RNA polymerase II. In
contrast, IAV Pol not only is responsible for synthesizing every
viral RNA genome but also amplifies viral RNAs multiple times
per infection cycle, which gives IAV Pol ample chances to generate
mutations in every infection event.
IAV Pol has been qualitatively studied for its RNA-dependent
RNA polymerase activity using various biochemical settings
[6,7,8]. However, the mechanistic studies of IAV Pol complex,
which determine basic kinetic parameters of the polymerases such
as the nucleotide binding affinity, conformational change and
chemical catalysis, have not been explored. This is because of
several technical difficulties that have hindered this type of
biochemical analysis for IAV Pol. First, the expression and
purification of IAV Pol has been less than optimal for producing a
large quantity of the active enzyme, simply because it is technically
more challenging to express and purify the IAV Pol complex
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e10372which consists of three different subunits, PA, PB1 and PB2, as
compared to other single subunit polymerases such as HIV-1 RT.
Second, polymerase studies which determine the basic kinetic
parameters of DNA/RNA polymerases employ pre-steady state
conditions instead of the steady state condition [9,10]. However,
since the pre-steady state condition requires the saturation of the
template/primer complex used (100–200 nM) by the polymerase,
a large amount of the purified polymerase is necessary for this type
of analysis. Third, the IAV Pol assays use very high concentrations
(mM) of primers such as ApG and cellular mRNAs, while other
polymerase assays (i.e. HIV-1 RT) employ much lower concen-
trations of the primers (10–100 nM). Therefore, under the current
IAV Pol reaction conditions available, only a fraction of the total
primer is extended in each polymerase reaction, and thus the use
of the 59 end labeled primers, which are routinely used in kinetic
assays of other polymerases, are not easily applicable to the IAV
Pol assay.
Most frequently used polymerization assays of IAV Pol in
current studies are gel-based standing start primer extension
reactions that incorporate NTP substrates using ApG or cellular
mRNAs as primers. In typical IAV Pol assays, one of the four
NTPs is an a-
32P-labeled radioactive NTP (i.e. a-
32P-GTP), which
aids in the visualization of the extended products, and the other
three NTPs are nonradioactive (i.e. ATP, CTP and UTP),
[6,7,8,11,12]. However, while the three nonradioactive NTPs
are normally used at mM ranges, the concentration of the
radioactive NTP (i.e. a-
32P-GTP) is relatively very low (0.08 to
50 mM), simply because the highly concentrated radioactive NTP
is not readily available, and use of a large quantity of radioactivity
is technically challenging. Indeed, many recent reports that studied
the steady state kinetic NTP incorporation by IAV Pol still used
approximately 1/100 to 1/1000 biased nucleotide pools for the
radioactive NTP (i.e. GTP) to the other three nonradioactive
NTPs (i.e. ATP, CTP and UTP) [8,13,14]. These unbalanced
NTP pools in the reaction raise several concerns. First, it is highly
likely that the use of 100- or 1000-fold lower concentration of the
radioactive GTP, as compared to the three other nonradioactive
NTPs, induces a serious polymerase kinetic bias: the entire IAV
Pol reaction rate is simply dependent on the limited availability of
radioactive GTP in the reaction, ultimately leading to the
underestimation of the kinetic activity of IAV Pol. Second, biased
NTP pools are a well known factor for mutagenesis [15], implying
that some of the extension products, which were used for assessing
polymerase activity, are actually the products of mutation
synthesis. Third, it is well established that cellular NTP
concentrations range between 0.25–3 mM (mM, ATP, 3,152 +/2
1,698; GTP, 468 +/2 224; UTP, 567 +/2 460 and CTP,
278 +/2 242) [16].
In this report, we established new assay conditions that use
unbiased and biologically relevant NTP substrate concentrations
and avoid the kinetic bias found in the currently available gel-
based assays. Importantly, this adjustment of the assay conditions
not only revealed the robust polymerase activity of IAV Pol
complex, but also enabled us to investigate the enzyme fidelity of
IAV Pol. Also, with this new assay condition, we were able to
conduct a series of comprehensive biochemical analysis to study
the impact of various reactions parameters such as temperature,
metals and viral NP on the IAV Pol fidelity. Overall, our results
suggest that IAV Pol is least error-prone when compared to two
reverse-transcriptases, HIV-1 RT and MuLV RT and also to
bacterial phage T7 RNA polymerase. Importantly, the biochem-
ical finding of the high fidelity nature of IAV Pol introduces a new
concept of the mechanistic relationship between IAV Pol fidelity
and the IAV replication strategy which uniquely provides IAV Pol
with ample opportunities to generate genomic mutations during
the multiple rounds of cRNA and vRNA amplification in a single
infection cycle.
Materials and Methods
Expression and purification of influenza A virus RNA
polymerase complex and other polymerases
For IAV polymerase, the PA, PB1 and PB2 genes (codon-
optimized, Geneart) were amplified by reverse-transcription PCR
from the H3N2 IAV strain (A/chicken/Nanchang/3-120/01),
obtained from Dr. R. Webster, St. Jude Children’s Research
Hospital, Memphis, TN, USA. They were then cloned to the
baculovirus expression vector pVL1392 (Invitrogen) between the
BglII and XbaI sites. The PA gene was tagged at the C-terminus
with the tandem affinity purification (TAP) tag, which consisted of
a thrombin cleavage site followed by 6X His tag, tobacco etch
virus (TEV) cleavage site and finally an IgG-binding domain. Each
of the three pVL1392 plasmids were individually transfected into
Sf9 insect cells for the production of recombinant viruses in
SF900II SFM media (GIBCO), following the protocols provided
by the vendor (BD Biosciences Pharmingen). To prepare the
purified trimeric IAV polymerase, the three recombinant viruses
were used for coinfecting Tni insect cells grown in Express Five
SFM media supplemented with L-Glutamine (GIBCO). Cells were
harvested 72 hours post infection and the lysates obtained were
purified by the TAP purification technique as described previously
[12,17]. Typically, 1l expression culture produced 0.7 mg of the
purified complex with approximately 95% purity, which was
qualitatively compared with the band intensity of BSA with 95%
purity (Sigma-Aldrich).The approximate molar ratio of
PA:PB1:PB2, which was estimated by the protein band intensity
in SDS-PAGE, was 1.8:1:1. T7 RNA polymerase was purchased
from Ambion, and HIV-1 and MuLV RT proteins were isolated
in our previous study [18].
Overexpression and purification of H3N2 NP in E. coli
The H3N2 Nanchang NP gene (A/Chicken/Nanchang/3-120/
01) was cloned to pET28a (Novagene), expressing NP protein
fused to the six histidine tag at its N-terminal end. NP was purified
using Ni
++ column chromatography following the protocol
provided by the vendor (Novagen). Fractions containing NP were
pooled and dialyzed to a low salt buffer (50 mM Tris-Cl (pH 7.5),
1 mM EDTA, 200 mM NaCl, 10% glycerol, 1 mM DTT). The
dialyzed protein was further purified using a second DEAE-
Sephacel column to minimize any RNase contamination. The
RNA binding of the purified NP was examined by a filter binding
assay employing both protein and nucleic acid binding filters (data
not shown).
Template preparation
59 vRNA (59 AGUAGAAACAAGGCC 39) and the 14-
nucleotide (nt) 39 vRNA which serves as a template (59
GGCCUGCUUUUGCU 39) from the PA gene of influenza A
virus were purchased from Dharmacon. The other two templates
(50-nt and 137-nt) used encode the first 50-nt and 137-nt
sequences from the 39 end of the Nanchang PA gene. The 50-nt
template was purchased from Integrated DNA Technologies. The
137-nt RNA template was prepared by in vitro transcription using a
double stranded (ds) PCR product amplified by a 37-mer forward
primer encoding T7 promoter sequence and 19-nt of the viral
sequence and a 16-mer reverse primer encoding 39 sequence of the
PA gene. The PCR product was used for synthesizing the 137-mer
Influenza Polymerase Fidelity
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purified as described [19].
For the IAV Pol misincorporation reactions, a 30-nt RNA
template (59 GCAUUGUCGCAAUCAGUACCUGCUUUCG-
CU 39) encoding the first 30-nt sequence from the 39end of the PA
gene was used (Integrated DNA Technologies). The T7 template
sequence (59 TAATACGACTCACTATAGGCGAAAGCAGG-
TACTGATTGCGACAATGC 39) contains the T7 promoter
region which is the first 18 nucleotides and the remaining 29
nucleotides (see the sequence underlined) are the same sequence as
that of the flu template. The first A nucleotide is deleted because
T7 pol requires G at the +1 site. This also explains why the T7
bands run one nucleotide lower than the IAV Pol reaction bands
on the PAGE. For the HIV-1 RT and MuLV RT reactions, a 48-
nt RNA template is used. This 48-mer RNA template
(59 GCAUUGUCGCAAUCAGUACCUGCUUUCGCUCUGGC-
UUAAGGGCGAUCG 39) encodes not only the same first 30-nt
sequence of the PA gene as the 30-mer Flu Pol template, but also the
18-nt non-PA gene which is annealed to a 18-mer DNA primer
containing the A–G sequence at its 39 end.
ApG initiated RNA transcription
We tested the transcriptional activity of the purified polymer-
ase complex using the ApG transcription assay in which the 39
and 59 vRNA and the dinucleotide primer, ApG (Biosynthesis)
are provided. ApG was extended using the 39 vRNA template
(14-nt) by the IAV polymerase (200 ng), generating a 14-nt long
RNA fragment product. The ApG transcription reactions were
performed as described elsewhere [20] at 37uCi n5mlr e a c t i o n s
mixtures containing transcription buffer (25 mM Tris-Cl, pH 7.5,
100 mM KCl, 5 mM Mg(OAC)2, 0.1 mM EDTA, 2 mM DTT,
0.25 ml Nonidet P-40, 12.5% glycerol), IAV Pol complex,
0.25 U/mlR N a s i n ,0 . 3 m MA p G ,1 . 6 mM1 4 n t3 9vRNA,
1.6 mM5 9vRNA, 0.08 mM radioactive a-
32P-GTP (0.125 ml
GTP, 3000 Ci/mmole, Perkin Elemer), and varying concentra-
tions of nonradioactive NTPs (ATP, CTP, GTP and UTP) as
described in figure legends. Transcription reactions were stopped
after 1 h by the addition of 5 ml trichloroacetic acid (TCA) dye,
denatured at 95uC for 3 min and transcription products were
separated by 8 M urea denaturing 18–20% polyacrylamide gel
electrophoresis (PAGE). The dried gels were analyzed by
autoradiography using a PhosphorImager (Molecular Dynamics)
and the intensity of the fully extended products was quantitated
by OptiQuant (Version 3.10, Packard Instrument). In order to
validate the linearity of the radioactive signals in this assay, we
determined the signal intensity of the samples diluted by known
ratios (i.e. 1, 1/2, 1/4, 1/8 and 1/16), and used that for all
subsequent analysis of the signals. In the reactions described in
Figure 1 which used varying amounts of radioactive and
nonradioactive GTP, the ApG-primed reactions were performed
in the presence of every 10-fold increasing concentrations of the
nonradioactive GTP (0.1, 1, 10, 100 and 1000 mM) with 0.08 mM
of radioactive a-
32P-GTP and 1 mM of other three nonradioac-
tive NTPs (ATP, CTP and UTP).
Misincorporation assay
In the misincorporation assays with all four polymerases, an
equal concentration of all the nucleotides (NTPs or dNTPs) was
provided using a mix of four a-
32P-NTPs or dNTPs (0.16 mM,
PerkinElmer, specific activity, 3000 Ci/mmol) and nonradioactive
NTPs or dNTPs (500 mM). For IAV Pol, the ApG-transcription
reactions were performed with the 30-nt 39 RNA template as
described (Figure 2A), and the reactions were repeated with only
three kinds of NTPs after deleting ATP [(2) A] or UTP [(2) U].
Similarly, for the T7 RNA polymerase reactions, 2 mlo f
normalized protein (Ambion) was mixed with 50 nM ds DNA
template containing T7 promoter (Figure 2A) in the provided
reaction buffer at 37uC for 1 hr. For HIV and MuLV RT, a
mixture of 200 nM 48-mer RNA template annealed to 100 nM
18-mer DNA primer (Figure 2A), 500 mM dNTPs, 0.16 mM a-
32P-
dNTPs (PerkinElmer, 3000 Ci/mmol) were incubated with RT for
1 hour at 37uC under conditions described previously (16). In the
(2) A and (2) T reactions, dATP and dTTP were left out,
respectively.
For further biochemical characterization, misincorporation
reactions were carried out at various temperatures (30, 37, 39
and 42uC). For testing the effect of Mn
++, Mg(OAC)2 (5 mM) in
the buffer was replaced with varying concentrations of MnCl2 (0.5,
1, 5, 7.5 mM). Further, the reactions were performed with and
without different amounts of purified NP. For reactions with NP,
NP was preincubated with the RNA template prior to the addition
of IAV Pol in the reaction mixture. Note that to minimize any
loading variations between reactions, which can affect the total
activity measurement, we added an equal amount of a 59 end
32P-
labeled non specific primer to each reaction, and used this as the
loading control (i.e. ‘‘LC’’ Figure 3). The transcription products in
all the misincorporation reactions were separated by 8 M urea
denaturing 18–20% PAGE.
Results and Discussion
RNA polymerase activity of IAV Pol complex using
biologically relevant NTP concentrations
First, in order to address the potential kinetic bias induced by
the biased NTP pools that have been typically used in the gel-
based IAV Pol assays, we conducted the ApG-initiated IAV RNA
polymerase reaction using gradually increasing concentrations of
the limited NTP (GTP) in the reaction, which abolishes the NTP
pool bias (Figure 1). The ApG-primed reactions were performed in
the presence of every 10-fold increasing concentrations of the
nonradioactive GTP (0.1, 1, 10, 100 and 1000 mM) with a
0.08 mM of radioactive a-
32P-GTP and 1 mM of other three
nonradioactive NTPs (ATP, CTP and UTP). The polymerase was
expressed and purified from the baculovirus system as we
described previously [17]. The reaction mixtures contained the
Nanchang H3N2 IAV Pol complex, ApG (0.3 mM), 59 RNA 15-
mer (1.6 mM), and one of three different 39 RNA templates, 14-nt
(Fig. 1A), 50-nt (Fig. 1B) and 137-nt (Fig. 1C) encoding the 39 end
sequence of the Nanchang IAV PA gene. The reactions were
performed at 37uC for 60 min, and were analyzed by denaturing
8 M urea-PAGE. The extent of the fully extended products, which
is indicative of the polymerase activity in the multiple nucleotide
incorporation assays, was determined.
Importantly, note that the actual portion of the radioactive
a-
32P-GTP proportionally decreases upon mixing with every 10-
fold increase in concentration of the nonradioactive GTP (0.1, 1,
10, 100 and 1000 mM, lanes 1 to 5 in Fig. 1). Thus, the NTP bias
was abolished in the reaction with 1000 mM nonradioactive GTP
where the portion of the radioactive GTP (0.08 mM) is minimal in
the final GTP concentration (1000.15 mM). If the polymerase
activity remains unchanged under this condition, the radioactive
GTP incorporation in the primer extension, which can be
visualized and quantitated from the radioactive band intensity of
the extended products, should proportionally decrease, due to the
increasing probability of the nonradioactive GTP incorporation
instead of a-
32P-GTP. However, as shown in Figure 1, in all of the
reactions with the three different RNA templates, we did not
observe the predicted proportional 10-fold reduction of the fully
Influenza Polymerase Fidelity
PLoS ONE | www.plosone.org 3 April 2010 | Volume 5 | Issue 4 | e10372extended products (14-nt, 50-nt and 137-nt), implying that the
polymerase activity of the Pol complex was actually elevated when
the total GTP concentration increased. This observation with the
different sized templates indicates that the effect of GTP
concentration on the activity of the enzyme is consistent,
regardless of the sequence and size of the template.
Next, we plotted the actual extent of the full length products in
the 50-nt (Fig. 1D) and 137-nt (Fig. 1E) template reactions, which
corresponds to the total IAV Pol activity in each reaction. The
observed activity is then compared with the expected activity i.e.,
the predicted product extent which should decrease ten times with
every 10-fold increase of nonradioactive GTP concentration. As
seen in the plots of the data from the 50-nt (Fig. 1D) and 137-nt
products (Fig. 1E), the total IAV Pol activity measured from the gel
analysis was significantly higher than the expected activity.
Strikingly, fully extended products were able to be detected in
the reaction with an equal 1000 mM of all four NTPs (Fig. 1, lanes
5) where only ,0.01% of the total GTP was radioactive. Thus,
this data suggests that the polymerase activity of H3N2 IAV Pol
must have been elevated at least 200–500 times when we used a
1000 times higher concentration of the final GTP than the
concentration that has typically been used in various recent
studies. This observation also implies that the IAV Pol activity has
been underestimated in the IAV Pol assay that employed limited
GTP because the reaction rate at this limited GTP pool is likely
below Vmax.
Figure 1. NTP concentration dependent ApG-primed RNA polymerase activity of IAV Pol complex. ApG primer (0.3 mM) was extended
by IAV Pol using RNA templates encoding the first 14 (A), 50 (B) and 137 (C) nucleotides (nt) 39 end sequences of the IAV PA gene. RNA
polymerization was initiated by adding 1 mM ATP, 1 mM UTP, 1 mM CTP, 0.08 mM a-
32P-GTP, and varying concentrations of nonradioactive GTP
(lanes 1-5; 0.1, 1.0, 10, 100 and 1000 mM). M: Size markers C: Negative control without polymerase. F: Fully extended products. The fully extended
products observed in the reaction with 50-nt (D) and 137-nt (E) were determined by densitometric analysis (observed activity) and these values were
plotted against the actual GTP concentrations used in each reaction. The activity at 0.1 mM GTP was set arbitrarily to 100%.
doi:10.1371/journal.pone.0010372.g001
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It has been well-established that a biased nucleotide pool is a
major factor to promote polymerase-induced mutation synthesis
[21]. Basically, polymerases pause at the template sequences where
the limited nucleotides are supposed to be incorporated, and the
temporal pausing of the polymerase triggers the incorporation of
an incorrect nucleotide, called misincorporation, which eventually
generates mutations. Therefore, another important indication of
the data presented in Figures 1 would be that the full extended
products observed in the significantly biased NTP pools could
include the products of misincorporation to some extent,
particularly at low total GTP concentrations (Fig. 1, lanes 1).
In fact, one commonly used assay to investigate the enzyme
fidelity of polymerases is a primer-extension based misincorpora-
tion assay employing completely biased nucleotide pools that
consist of only three of nucleotides instead of all four nucleotides
Figure 2. Misincorporation assay with IAV Pol, bacterial phage T7 RNA polymerase, HIV-1 RT and MuLV RT with biased nucleotide
substrate pools. (A) Template sequences used for the misincorporation assay with IAV Pol, T7 RNA polymerase and RTs of HIV-1 and MuLV. The IAV
Pol template used is a 30-nt sequence from the 39 end of the viral PA sequence with a ApG primer binding site (P:primer, T:template,). The first UTP or
TTP incorporation site of each template was marked with ‘‘X’’, and the first stop site in the (2) UTP or TTP reaction was marked with ‘‘1*’’ under each
template sequence (the second and third stop sites were marked ‘‘2*’’ and ‘‘3*’’ for the IAV template). The RNA synthesis initiation sites were marked
in blue. (B) ApG-initiated RNA-dependent RNA polymerization by IAV Pol: ApG primer was extended with a 30-nt RNA template and three different
amounts of H3N2 IAV Pol protein (1x, 2x and 3x) with 500 mM four NTPs (‘‘4’’) and 0.16 mM a-
32P-GTP, and the same reactions were repeated except
using two biased NTP pools, minus UTP (‘‘- U’’) or minus ATP (‘‘- A’’). The sequence of the incorporated nucleotides near the three UTP stop sites (red)
is shown at the side. The extended products in the (2) UTP reaction, which was used for calculating the misincorporation efficiency, was marked as
‘‘]’’.Dotted lines refer to RNAs. (C) DNA dependent RNA polymerization of bacterial phage T7 RNA polymerase: A 47 bp ds DNA (box) encoding T7
promoter (grey box) and 29 bp sequence (white box) was used for RNA synthesis with T7 RNA polymerase at 37uC for 60 mins. ‘‘]’’: Fully extended
misincorporated product. (D) and (E) RNA dependent DNA polymerization reaction by HIV-1 RT (D) and MuLV RT (E). A 48 mer RNA template
annealed to a 18-mer single stranded DNA primer was used for the DNA polymerization by HIV-1 and MuLV RTs at 37uC for 60 mins. 500 mM dNTPs
mixed with a-
32P-dNTPs (0.16 mM), which is the same nucleotide concentration and ratio as used in the reactions with IAV Pol and T7 RNA
polymerase, was used for DNA synthesis. ‘‘]’’: Fully extended misincorporated product. Dotted lines refer to RNA and solid lines refer to DNA. (F) and
(G) Comparison of the misincorporation efficiency of the four polymerases. For calculation of the misincorporation efficiency, the fully extended
misincorporated product in (2) U/(2) T reactions in all four polymerases was normalized to the total extended product in the lanes with all four NTPs
(dNTPs). The fold differences of the calculated misincorporation percentages between three activities of IAV Pol (F) and between IAV Pol and three
other polymerases (G) were determined. At least five repeats of the assay were conducted in this analysis.
doi:10.1371/journal.pone.0010372.g002
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primer extension pauses at one nucleotide before the template
sequence that the deleted nucleotide is supposed to be incorpo-
rated, called a ‘‘stop site’’. However, low fidelity enzymes tend to
efficiently incorporate incorrect nucleotides at the pause sites, and
display the efficient primer extension products beyond the stop
sites, whereas high fidelity enzymes exhibit little primer extension
beyond the stop sites. The efficiency of the primer extension
beyond the first stop site in the total primer extension has been
used to compare the enzyme fidelity between polymerases
[5,22,25].
For this test, we performed the 30-nt template-based and ApG-
initiated polymerization reactions in which a mixture of all four
NTPs (or three in case of misincorporation reactions) are provided.
The ratio of radioactive NTP to nonradioactive NTP is kept
constant for all the NTPs and is approximately 1/1600, allowing
us to use a low concentration of radioactive NTPs. The 30-nt
template also encodes the 39 end 30-nt sequence of the viral PA
gene template (Figure 2A). As shown in Figure 2B, in the reaction
with all four NTPs (500 mM), H3N2 IAV Pol complex extended
the ApG primer and generated the 30-nt long fully extended
products, and the extents of the fully extended products were
Figure 3. Effect of temperature on polymerase activity and misincorporation efficiency of IAV Pol complex. (A) IAV polymerization at
different temperatures. LC: loading control (B) Fully extended products for the polymerase activity of IAV Pol at the four different temperatures were
compared after being normalized with the value obtained at 30uC (100%). (C) The misincorporation efficiency of IAV Pol at four temperatures were
calculated as described in Figure 2F, and compared with the value obtained at 30uC (100%). C: no polymerase control.
doi:10.1371/journal.pone.0010372.g003
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reaction conditions (1x, 2x and 3x: Fig. 2B, 3X=200 ng),
confirming that the NTP incorporation kinetics was linear under
the employed polymerase reaction. Upon the deletion of UTP or
ATP from the four NTPs [(2) U or (2) A in Fig. 2B], however, the
amount of fully extended products were significantly reduced,
indicating that the biased NTP pool generated major kinetic
blockages in the IAV Pol polymerization reaction. As predicted,
the first ‘‘stop site’’ was observed at one nucleotide before the sites
where the deleted UTP (‘‘X’’ in Fig. 2A) should be incorporated
(Fig. 2A and 2B: see ‘‘1*’’ in the (2) U reactions of and the
sequences of the expected products). Excitingly, primer extension
was observed beyond the first stop site, generating the second
(‘‘2*’’) and third (‘‘3*’’) stops sites (Figure 2A and 2B). This
indicates that mutation synthesis must have occurred at not only
the first stop site but also the later stop sites.
Unlike the UTP stop sites, it is difficult to observe the first stop
sites induced by the deletion of other three NTPs (A, G and C)
because the first 5 nucleotides in the 39 end conserved sequence of
the IAV genomes contain A, G and C. Thus, their first stop sites
generate only 3–5 nucleotide long products which are technically
difficult to separate even with 8 M urea high percentage
denaturing PAGE. However, as shown in the reactions with (2)
ATP pool (Fig. 2B), the full length extension was also significantly
decreased which supports that the biased NTP pool generates
kinetic blockage. Interestingly, the sixth ‘‘A’’ incorporation site is
present at the 18th nucleotide from the 39 end of the 30-nt
template sequence and this could be observed in the (2) ATP
reaction (‘‘6*’’) in Figure 2B. The product seen at the sixth A
incorporation site must have been generated after IAV Pol made
mutations at the five different stop sites prior to the fifth sixth stop
site seen in the gel. Importantly, we observed that the reactions
with (2) CTP or (2) GTP biased pools also induced the reduction
of the fully extended product (data not shown). Indeed, this is the
first biochemical observation reported for mutation synthesis by
IAV Pol.
Misincorporation efficiency of bacterial T7 RNA
polymerase, HIV-1 RT and MuLV RT with templates
encoding identical sequences
Next, we compared the enzyme fidelity of IAV Pol complex
with three other polymerases, bacterial phage T7 DNA-dependent
RNA polymerase as well as two retroviral RNA-dependent DNA
polymerases which are well-characterized for their fidelity [26]: 1)
murine leukemia virus reverse transcriptase (MuLV RT) with high
fidelity and 2) human immunodeficiency virus Type 1 reverse
transcriptase (HIV-1 RT) with low fidelity [18,24,26,27] Impor-
tantly, these polymerases initiate the nucleic acid synthesis by
using their own unique template and primer complexes (i.e. double
stranded DNA with promoter sequence for T7 RNA polymerase,
and a DNA primer annealed to a RNA template for RTs) as
illustrated in Figure 2A. First, we conducted a RNA synthesis
reaction with T7 RNA polymerase under the same NTP
concentration and ratio between radioactive and nonradioactive
GTP (1/1600) as the IAV reaction except for the template
sequence. As illustrated in Figure 2A, the T7 Pol template used is a
47-bp double stranded DNA (Fig. 2C) containing 18-bp T7
promoter and 29-bp of the sequence which is the same as the IAV
RNA Pol template. The first nucleotide of the RNA product starts
from G instead of A because T7 Pol prefers G as the initial
nucleotide in RNA synthesis [28]. We also used the T7 Pol activity
which displayed a similar level of the fully extended product as the
IAV Pol reaction (Fig. 2B). As shown in Figure 2C, the first (2)
UTP stop site was observed in the T7 Pol reaction (‘‘1*’’ in
Fig. 2C). However, a significantly high level of the fully extended
product was observed (see ‘‘]’’ in Fig. 2C), compared to the IAV
Pol reaction with (2) UTP (see ‘‘]’’ in Fig. 2B).
Next, we conducted the (2) dTTP and (2) dATP misincorpora-
tion assay with low fidelity HIV-1 and high fidelity MuLV RT
proteins. The RT reactions employed a 48-nt RNA template
encoding the 39 end 30-nt sequence of the PA gene and 18-nt non-
viral sequence annealed to an 18-nt DNA primer (Fig. 2A). Thus,
the single stranded 30-nt PA sequence of the 48-mer RNA
template where DNA synthesis is catalyzed by RTs encodes the
exactly same 30-nt sequence as the influenza Pol 30-nt template
used in Figure 2B. The RT reactions were conducted using the
same nucleotide substrate (dNTP) concentration and the same
ratio between nonradioactive and radioactive dNTP (1/1600) as
the IAV Pol and T7 RNA Pol reactions. First, we normalized the
polymerase activity of HIV-1 and MuLV RTs showing a similar
band intensity of the fully extended product with all four NTPs as
the full length bands in the 1x activity of the IAV Pol reactions
(Fig. 2B). Importantly, note that the specific activities of the a-
32P-
NTP and a-
32P-dNTP, which were used in the IAV Pol and RT
reactions, respectively, were identical (3000 Ci/mmole), and thus
the same band intensity of the fully extended products in the
reactions with different polymerases indicates the same level of
nucleotide incorporation and nucleic acid synthesis.
Next, we repeated the same RT reactions with the equal activity
of low fidelity HIV-1 and high fidelity MuLV RTs but with the (2)
TTP or (2) dATP biased pools. Indeed, HIV-1 RT displayed
much more extension beyond the first stop site (‘‘1*’’: see the sites
marked with ‘‘U’’ in Figure 2D) and full length products (see ‘‘]’’ in
Fig. 2D) than MuLV RT (Fig. 2E). This observation not only
confirms that HIV-1 RT is more error-prone than MuLV RT, but
also validates the fidelity assay condition established in this study.
We also confirmed the first stop sites in these RT reactions using
the same primer extension reactions but with 59 end c-
32P-labeled
DNA primer and four different biased dNTP pools (data not
shown).
Now with the misincorporation assays completed with the three
other polymerases, we were able to compare their enzyme fidelity
by comparing the extent of the primer extension beyond the first
stop site (see ‘‘*’’ in Fig. 2). First, as seen in Figure 2B (1x) for IAV
Pol with (2) UTP and Figure 2D for HIV-1 RT with (2) TTP,
IAV Pol generated much shorter and fewer RNA products beyond
the first stop site than HIV-1 RT even if there was a 2-fold more
total polymerase activity of the 1x IAV Pol than HIV-1 RT, which
was estimated from the reaction with all four nucleotides present.
This suggests that IAV Pol complex has a lower misincorporation
capability than HIV-1 RT. Also, HIV-1 RT showed much higher
extension beyond the first stop site (Fig. 2D) than MuLV RT
(Fig. 2E), suggesting that HIV-1 RT has lower fidelity than MuLV
RT, which has been demonstrated previously (25). Interestingly,
IAV Pol complex generated similar or slightly less primer
extension beyond the first stop site than the high fidelity MuLV
RT even if a lower polymerase activity of MuLV RT, compared to
IAV Pol, was used, supporting that IAV Pol complex has at least
similar fidelity with MuLV RT. Overall, the data shown in
Figure 2 qualitatively suggests that IAV Pol complex is a high
fidelity enzyme.
It is important to address that IAV Pol may fall off from the
template during the initial synthesis [14], which can induce the
pausing of the primer extension reaction, and this is also true for
several RNA polymerases using the promoter such as T7 RNA
polymerase used in this study [29]. Since our study observes the
pausing events at 11–13 nt away from the first nucleotide
incorporation, the intrinsic pausing nature of these polymerases
Influenza Polymerase Fidelity
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that some fraction of the pauses observed in our study may result
from the pausing induced during the initiation of RNA synthesis.
In addition, there are a number of other factors known to affect
the processivity of polymerases such as template sequences,
template RNA secondary structures, substrate availability, salt,
and temperature. In this study, we employed identical template
sequences for all four enzymes to minimize any template-induced
pausing.
Quantitative comparison of the misincorporation
efficiency of IAV Pol complex with T7 RNA polymerase,
HIV-1 RT and MuLV RT
Finally, we estimated the fidelity difference between IAV Pol
and three other enzymes analyzed in Figure 2. Since in the assay
described in Figure 2, the misincorporation level is proportional to
the total polymerase activity used, we could simply calculate the
misincorporation efficiency in the (2) UTP (or TTP) reactions
with each of the four polymerase reactions by normalizing the
band intensity of the total misincorporated product (‘‘]’’) of the (2)
UTP (or TTP) reaction with the band intensity of the total
polymerase activities used which is represented by the full length
products in the all four nucleotide reactions. First, we examined if
the misincorporation efficiency remains similar in the reactions
with three different activities of IAV Pol (1x, 2x and 3x: Fig. 2B).
As shown in Figure 2F, the misincorporation efficiency of IAV Pol
was relatively constant regardless of the IAV Pol activity used, and
this validates that the polymerase activity and reaction conditions
employed in Figure 2 are proper for fidelity comparisons. Second,
HIV-1 RT showed 3 times higher misincorporation efficiency than
MuLV RT in this gel based assay. In fact, HIV-1 RT previously
showed 4 to 10 times lower fidelity than MuLV RT in various
fidelity assays (1, 29, 31) and this further validates our gel based
assay system. With this validation, next, we calculated and
compared the misincorporation efficiency of IAV Pol with the
three other polymerases. As summarized in Figure 2G, indeed,
IAV Pol is 7 and 2.3 times less error-prone than HIV-1 and
MuLV RTs, respectively, and 6.1 times less error-prone than T7
RNA polymerase. Importantly, since all of the four polymerases
used in Figure 2 lack 39 to 59 proof-reading activity, the mutation
synthesis observed in the misincorporation assay must be catalyzed
only by their polymerase active sites.
Effect of temperature, Mn
++, and influenza nucleoprotein
(NP) on the misincorporation efficiency of IAV Pol
complex
Previous studies with various DNA and RNA polymerases
demonstrated that the enzyme fidelity of DNA polymerases is
highly sensitive to reaction conditions such as metals [30,31] and
reaction temperature [32,33]. Next, by using the physiological
NTP condition showing robust activity of IAV Pol and the
misincorporation assay established in Figure 2, we investigated a
series of comprehensive biochemical characterizations for the
effects of the temperature, Mn++ and viral RNA binding protein,
NP, on the polymerase activity and fidelity of IAV Pol. First, we
examined the effect of the temperature on the IAV Pol fidelity.
The ApG-initiated RNA synthesis was conducted in the presence
of all four NTPs or (2) UTP mix by the IAV Pol complex at 30,
37, 39 and 42uC for 1 hr. Note that to minimize any loading
variations between reactions, which can affect the total activity
measurement, we added an equal amount of a 59 end
32P-labeled
non specific primer to each reaction, and used this as the loading
control (‘‘LC’’ Figure 3). The fully extended products in the
reactions with all four NTPs were used for estimating the
temperature dependence of IAV RNA polymerase after being
normalized with the loading control (LC) band intensity. As shown
in Figure 3A and 3B, the H3N2 IAV Pol complex showed the
highest polymerase activity at 37uC and its activity largely
decreased at 42uC. However, while the polymerase activity
significantly reduced at 42uC, the level of the misincorporation
beyond the 1
st stop site at 42uC remained similar with the
reactions at lower temperatures. Since the misincorporation
capability was defined as the ratio of the level of the primer
extended beyond the first stop site with the biased NTP pool to the
total polymerase activity measured in the reaction with all four
NTPs, the misincorporation capability of IAV Pol actually
increased at 42uC, compared to that at the lower temperatures.
Indeed, when the misincorporation efficiency at each temperature
was calculated (Fig. 3C), the IAV Pol complex was more error
prone at 42uC compared to the low temperatures. In fact, this
temperature effect of the IAV Pol fidelity is novel because our
previous study with RT proteins showed elevated fidelity at high
temperatures such as 55uC [32]. In addition, the optimal
temperature for the IAV Pol activity varies among viral strains
as we recently reported [12], and avian strain Pol complexes
appear to display its optimal activity at higher temperature in
general [34].
Mg
++ is a common metal ion used by DNA and RNA
polymerases which essentially facilitates the nucleophilic attack of
the 39 OH at the primer to the a-phosphate of the incoming
nucleoside triphosphate to form a phosphodiester bond. It has been
shown that replacing Mg
++ with Mn
++ promotes mutation synthesis
in some DNA polymerases [35]. First, we examined the effect of
Mn
++ on the polymerase activity of H3N2 IAV Pol. 5 mM Mg
++,
which is commonly used in the IAV Pol assay, was used a control
(Figure 4A), and the same reaction was repeated with varying Mn
++
concentrations. As shown in Figure 4A and 4B, the H3N2 IAV Pol
showed muchlowerpolymerase activitywith 0.5mMMn
++ than the
reaction with 5 mM Mg
++. Interestingly, at 1, 5 and 7.5 mM Mn
++
the IAV Pol actually showed increased total NTP incorporation
than with 5 mM Mg
++. However, the primer extension at 1, 5 and
7.5 mM Mn
++ became highly distributive as shown by the
accumulation of abortive products, suggesting that the processivity
of IAV Pol significantly reduced at high Mn
++ concentrations. A
recent report which employed biased NTP pool conditions, also
showed increased activity by increasing Mn
++ concentration
although the activity with Mn
++ is much lower than Mg
++ [36]
Next, we calculated the misincorporation efficiency using the
equation described above. For this, we used the concentration of
Mn
++ which showed comparable activity to 5 mM Mg
++ i.e.,
0.5 mM Mn
++ without any processivity defect. Even after
normalizing these two reactions for activity differences, the reaction
with Mn
++ shows higher misincorporation. Thus, this data supports
numerous earlier reports in literature stating that Mn
++ promotes
mutation synthesis by inserting a higher ratio of incorrect to correct
substrate. Also, it leads to decreased hydrolysis of the mismatched
product which explains the abortive products in the figure [37].
Lastly, we investigated the effect of influenza virus NP which is
known to both bind viral RNA template as well as interact with the
IAV polymerase [38]. For this, we expressed and purified the
H3N2 NP protein in E. coli. Since one single NP molecule binds to
RNA every 24 nucleotides [38], the 30-mer RNA template used in
the previous figures is too short for this test. Thus we used the 50-
nt long RNA template which was used in Figure 1B. The IAV Pol
reactions were conducted in the absence and presence of varying
amounts of NP which can coat 100, 150 and 200% of the 50-nt
RNA template. As shown in Figure 5A and 5B, the polymerase
Influenza Polymerase Fidelity
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which has been previously observed [39]. However, upon the
normalization with the total activity, the misincorporation
efficiency decreased slightly in reactions with NP.
Virological implications of the high fidelity nature of IAV
Pol with respect to other RNA viruses
It has been well established that the enzyme fidelity of viral
polymerases is a main determinant for viral genetic hyper-
mutability and evolution; and in the case of HIV-1, the highly
error-prone HIV-1 RT is considered as a key contributor for viral
genomic hypervariability [5,40]. This concept has been supported
because alterations in the HIV-1 RT fidelity directly affect HIV-1
mutation rate [40]. Considering the high viral capacity of
influenza viruses to evolve both within and between host species
as well, the observation of the relatively high enzyme fidelity of the
IAV Pol complex was rather unexpected. Interestingly, however,
several primer extension based biochemical studies also reported
Figure 4. Effect of manganese on polymerase activity and misincorporation efficiency of IAV Pol complex. (A) IAV polymerization with
5 mM Mg(OAC)2 and varying concentration of MnCl2 (lanes 1 to 4, 0.5, 1, 5, 7.5 mM). LC: loading control (B) Fully extended products for the IAV Pol
polymerase activity with different metal concentrations were compared after being normalized with the value obtained with 5 mM Mg(OAC)2 (100%).
(C) The misincorporation efficiency of IAV Pol at 0.5 mM MnCl2 was calculated as described in Figure 2F, and compared with the value obtained with
5 mM Mg(OAC)2 (100%). C: no polymerase control.
doi:10.1371/journal.pone.0010372.g004
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a positive strand RNA virus, is a high fidelity enzyme [41].
Thus, we reasoned about the disagreement between high
genetic variability of IAV and relatively high enzyme fidelity of
IAV Pol complex found in this report. IAV has a replication (RNA
synthesis) strategy that amplifies their genomes many times per
infection by using exclusively their own polymerase complex
without any assistance from host RNA polymerases. This is
contrasted to retroviruses (i.e. HIV-1) that replicate their single
stranded RNA genomes into double-stranded proviral DNA in
two ways. First, HIV-1 replicate their RNA genome to proviral
double stranded DNA only twice per infection (conversion of (+)
single strand RNA genomes to (2) single strand DNA and then
conversion of the synthesized (2) DNA to double stranded
proviral DNAs) by using their own polymerases. Second, the RNA
genomes of every HIV-1 progenies are synthesized by host RNA
polymerase II by transcribing the proviral DNA integrated into the
host chromosomes. It is a reasonable assumption that the viruses,
which require a high level of genomic mutations for their evolution
and escape but have only a few chances to replicate their genomes
by their own polymerases (i.e. HIV-1), might have evolved to
harbor highly error-prone polymerases (i.e. HIV-1 RT) to
generate sufficient mutations in really limited chances. In contrast,
due to numerous rounds of the amplification of single viral RNA
genomes to viral RNAs only by the viral polymerase, IAV Pol has
ample chances to make and accumulate genomic mutations in
each viral infection cycle. It has been estimated that the viral burst
size in case of influenza, in one cycle of replication, is about 1000
[42], and thus influenza virus should undergo ,1000 rounds of
genome replication solely by viral RNA polymerase. If IAV Pol
Figure 5. Effect of H3N2 NP on polymerase activity and the misincorporation efficiency of the IAV Pol complex. (A) IAV polymerization
in the presence and absence of varying concentrations of H3N2 NP with the 50-mer template used in Figure 1B. Molar ratios between the RNA
template and NP molecule were altered between 0 and 2. The RNA template was preincubated with NP before adding the polymerase complex. LC:
loading control; (B) Fully extended products for the IAV Pol activity with different molar ratios of RNA/NP were compared after being normalized with
the value obtained with no NP (100%). (C) The misincorporation efficiency of IAV Pol was calculated as described in Figure 2F, and compared using
the value obtained with no NP (100%). C: no polymerase control.
doi:10.1371/journal.pone.0010372.g005
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the excessive production of unwanted genomic mutations,
ultimately leading to catastrophic mutagenesis. Thus, it can be
hypothesized that the high enzyme fidelity nature of IAV Pol
complex which was observed in this study may enable the viruses
to avoid this lethal hypermutagenesis. However, even with high
enzyme fidelity, the multiple amplification replication strategy may
allow the IAV to produce genomic mutations sufficient for viral
evolution and host adaptation.
The similar reasoning of the high fidelity viral RNA
polymerases envisioned above for IAV Pol can be applied to
polioviruses which also amplify their RNA genomes multiple times
per infection solely by their own high fidelity RNA polymerase. In
addition, it was demonstrated that the elevation of genomic
mutation rates of poliovirus, which is promoted by an antiviral
agent (ribavirin), results in the catastrophic mutagenesis [41,43],
supporting the notion that poliovirus is vulnerable to hyper-
mutagenesis, and thus their polymerase fidelity might have evolved
to be a faithful RNA polymerase. Therefore, since IAV has similar
genome replication strategy with poliovirus, a similar mechanistic
relationship between the high fidelity nature of the IAV Pol
complex and viral high genetic and evolutionary potentials can be
applied to influenza A virus.
It is also important to address other potential cellular events that
may generate IAV genomic mutations during viral life cycle. One
potential mechanism well established is host enzymes that can
chemically alter the structures of the nucleotide substrates.
APOBEC3G is a host cytidine deaminase which can convert to
C to U in the proviral DNA of HIV-1, and this event induce the G
to A mutation in viral genomic DNA post reverse transcription,
leading to lethal mutagenesis [44]. Interestingly, however, HIV-1
evolved to encode a unique accessory protein, Vif, which
counteracts the APOBEC3G and escape from the lethal
mutagenesis effect of APOBEC3G. Interestingly, while influenza
virus infection elevates the APOBEC3G expression, no anti-viral
activity was detected [45]. It was also reported that another type of
host deaminase, APOBEC3F, appears not to display anti-influenza
virus effect. In addition, various oxidated NTPs can be also
incorporated during viral RNA synthesis, which may also affect
IAV mutagenesis. Thus further studies on the mechanistic
interplays of IAV evolution with the IAV Pol fidelity and other
viral and host factors that can produce the IAV genomic
mutations are necessary to firmly address the sources of the IAV
genomic mutagenesis.
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